
Lupin Limited has informed the Exchange regarding a press release dated August 16, 2021, titled "Lupin Receives Tentative U.S. FDA Approval for Brivaracetam Tablets".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated August 16, 2021, titled "Lupin Receives Tentative U.S. FDA Approval for Brivaracetam Tablets".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin